Home » Topics » Regulatory

Regulatory
RSS

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Effexor XR cleared by FDA

Oct. 28, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...